The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Novel Roles of Unphosphorylated STAT3 in Oncogenesis and Transcriptional Regulation
Open accessAbstract
Signal transducer and activator of transcription 3 (STAT3) is phosphorylated on tyrosine residue 705 in response to growth factors or cytokines to form activated homodimers that drive gene expression. Because the stat3 promoter has a binding site for STAT3 dimers, the amount of STAT3 protein increases when STAT3 is activated (e.g., in response to interleukin 6). Unphosphorylated STAT1 is known to drive the expression of certain genes. To explore the possibility of a similar role for the induced expression of unphosphorylated STAT3, we overexpressed either Y705F STAT3, which can not be phosphorylated on residue 705, or wild-type STAT3 in normal human mammary epithelial cells or STAT3-null mouse cells. The levels of many mRNAs were affected strongly by high levels of either form of STAT3. Some genes whose expression was increased by overexpressed STAT3, but not by activated STAT3 dimers, encode well-known oncoproteins (e.g., MRAS and MET). In many tumors, STAT3 is activated constitutively, and thus the unphosphorylated form is likely to be expressed highly, driving oncogene expression by a novel mechanism. In addition, expression of the stat3 gene is increased strongly in response to interleukin 6, and the high levels of unphosphorylated STAT3 that result drive a substantial late phase of gene expression in response to this cytokine. Thus, unphosphorylated STAT3, which activates gene expression by a novel mechanism distinct from that used by STAT3 dimers, is very likely to be an important transcription factor both in cancer and in responses to cytokines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, their efficacy is diminished because the inherent transcriptional activity of unphosphorylated STAT3 could also drive the expression of oncogenes such as MET and MRAS by binding to NF-κB (18–21).”
From Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer (2022) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Second, the targeted STAT3 degradation can completely inhibit the transcriptional activity of both dimerized and monomeric STAT3 (19, 21, 26).”
From Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer (2022) · cites this paper as [21]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“and that basal STAT3 has been shown to have transcriptional activity under basal conditions [44,45]”
From Selective STAT3-α or -β expression reveals spliceform-specific phosphorylation kinetics, nuclear retention and distinct gene expression outcomes (2012) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
Der, S. D., Zhou, A., Williams, B. R. G., & Silverman, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15623 · Cited by 1,840
TRANSCRIPTIONAL RESPONSES TO POLYPEPTIDE LIGANDS: The JAK-STAT Pathway
Schindler, C., & Darnell, J. E. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003201 · Cited by 1,808
Specific Inhibition of Stat3 Signal Transduction by PIAS3
Chung, C. D., Liao, J., Liu, B., Rao, X., Jay, P., Berta, P., & Shuai, K. (1997) · Science · doi:10.1126/science.278.5344.1803 · Cited by 980
Enhanced DNA-Binding Activity of a Stat3-Related Protein in Cells Transformed by the Src Oncoprotein
Yu, C.-L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz, J., & Jove, R. (1995) · Science · doi:10.1126/science.7541555 · Cited by 931
Three-dimensional structure of the Stat3β homodimer bound to DNA
Becker, S., Groner, B., & Müller, C. W. (1998) · Nature · doi:10.1038/28101 · Cited by 802
Garcia, R., Bowman, T. L., Niu, G., Yu, H., Minton, S., Muro‐Cacho, C., Cox, C. E., Falcone, R., Fairclough, R., Parsons, S. J., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204349 · Cited by 756
Crystal Structure of a Tyrosine Phosphorylated STAT-1 Dimer Bound to DNA
Chen, X., Vinkemeier, U., Zhao, Y., Jeruzalmi, D., Darnell, J. E., Jr., & Kuriyan, J. (1998) · Cell · doi:10.1016/s0092-8674(00)81443-9 · Cited by 734
Regulation of the cyclin E gene by transcription factor E2F1.
Ohtani, K., DeGregori, J. V., & Nevins, J. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12146 · Cited by 640
The SIF binding element confers sis/PDGF inducibility onto the c‐fos promoter.
Wagner, B. J., Hayes, T. E., Hoban, C. J., & Cochran, B. H. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07898.x · Cited by 592
Research works printed but not linked: 1
- Reddy MVR, Chaturvedi P, Reddy EP. Src kinase mediated activation of STAT3 plays an essential role in the proliferation and oncogenicity of human breast, prostate and ovarian carcinomas. Proc AACR 1999;40:376.
Cited by
Sorted by citations
Items 201–300 of 404
Esmail, M. M., Saeed, N. M., Michel, H. E., & El‐Naga, R. N. (2021) · Toxicology Letters · doi:10.1016/j.toxlet.2021.04.018 · Cited by 37
Sun, P., Nallar, S. C., Raha, A., Kalakonda, S., Velalar, C. N., Reddy, S. P., & Kalvakolanu, D. V. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.105767 · Cited by 37
Role of Stat3 in Skin Carcinogenesis: Insights Gained from Relevant Mouse Models
Macias, E., Rao, D., & DiGiovanni, J. (2013) · Journal of Skin Cancer · doi:10.1155/2013/684050 · Cited by 40
Activation of STAT3 in thymic epithelial tumours correlates with tumour type and clinical behaviour
Chang, K., Wu, M., Jones, D., Chen, F., & Tseng, Y. (2006) · The Journal of Pathology · doi:10.1002/path.2041 · Cited by 35
Xiong, Q., Wu, S., Wang, J., Zeng, X., Chen, J., Wei, M., Guan, H., Fan, C., Chen, L., Guo, D., et al. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0144-8 · Cited by 36
“Activated STAT3 contributes to oncogenesis by promoting cell proliferation, preventing apoptosis, and impairing host anti-tumor immune responses [16, 17].”
Lahiri, T., Brambilla, L., Andrade, J., Askenazi, M., Ueberheide, B. M., & Levy, D. E. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12928 · Cited by 37
Self-citationHansen, L. J., Yang, R., Roso, K., Wang, W., Chen, L., Yang, Q., Pirozzi, C. J., & He, Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-07697-0 · Cited by 40
Regulation of hematopoietic cell development and function by Stat3
Pamela, A. H. (2009) · Frontiers in bioscience · doi:10.2741/3597 · Cited by 36
Brown, M. E., Bear, M. D., Rosol, T. J., Premanandan, C., Kisseberth, W. C., & London, C. A. (2015) · BMC Veterinary Research · doi:10.1186/s12917-015-0505-7 · Cited by 35
Cell-cell and cell-matrix adhesion in survival and metastasis: Stat3 versus Akt
Niit, M., Hoskin, V., Carefoot, E., Geletu, M., Arulanandam, R., Elliott, B. E., & Raptis, L. H. (2015) · BioMolecular Concepts · doi:10.1515/bmc-2015-0022 · Cited by 35
Hegde, S., Ni, S., He, S., Yoon, D., Feng, G., Watowich, S. S., Paulson, R. F., & Hankey, P. A. (2009) · Oncogene · doi:10.1038/onc.2009.202 · Cited by 36
Clevenger, C. V., Zheng, J., Jablonski, E. M., Galbaugh, T., & Fang, F. (2008) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-008-9074-8 · Cited by 35
Serum interleukin‐6 levels in response to methotrexate treatment in psoriatic patients
Elango, T., Dayalan, H., Subramanian, S., Gnanaraj, P., & Malligarjunan, H. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.05.007 · Cited by 35
Lattanzi, W., Corvino, V., Maria, V. D., Michetti, F., & Geloso, M. C. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140816817 · Cited by 36
Diallo, M., & Herrera, F. (2021) · FEBS Journal · doi:10.1111/febs.16116 · Cited by 36
Koganti, S. R. K., de la Paz, A., Freeman, A. F., & Bhaduri‐McIntosh, S. (2013) · Journal of Virology · doi:10.1128/jvi.02601-13 · Cited by 34
Cross-talk between Phospho-STAT3 and PLCγ1 Plays a Critical Role in Colorectal Tumorigenesis
Zhang, P., Zhao, Y., Zhu, X., Sedwick, D., Zhang, X., & Wang, Z. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0147 · Cited by 34
Kan, C. E., Cipriano, R., & Jackson, M. W. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3860 · Cited by 34
Lin, L., Yao, Z., Bhuvaneshwar, K., Gusev, Y., Kallakury, B., Yang, S., Shetty, K., & He, A. R. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu163 · Cited by 33
STAT5 regulation of BCL10 parallels constitutive NFκB activation in lymphoid tumor cells
Nagy, Z. S., LeBaron, M. J., Ross, J. A., Mitra, A., Rui, H., & Kirken, R. A. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-67 · Cited by 33
Anti-inflammatory therapies in TRAMP mice: delay in PCa progression
Kido, L. A., Montico, F., Sauce, R., Macedo, A. B., Minatel, E., Costa, D. B. V., de Carvalho, J. E., Pilli, R. A., & Cagnon, V. H. A. (2016) · Endocrine Related Cancer · doi:10.1530/erc-15-0540 · Cited by 34
Wang, C.-M., Hsu, C., Niu, H., Chang, C.-H., Cheng, J., & Shieh, J. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.07.005 · Cited by 33
Clinical Profile of Hyper-IgE Syndrome in India
Saikia, B., Rawat, A. K., Minz, R. W., Suri, D., Vignesh, P., Jindal, A. K., Sahu, S., Karim, A., Desai, M. M., Taur, P. D., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.626593 · Cited by 33
Gasperin, B. G., Rovani, M. T., Ferreira, R., Ilha, G. F., Bordignon, V., Gonçalves, P. B. D., & Duggavathi, R. (2014) · Theriogenology · doi:10.1016/j.theriogenology.2014.09.026 · Cited by 33
Expression of STAT3, MMP-1 and TIMP-1 in gastric cancer and correlation with pathological features
Huang, Y. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.849 · Cited by 33
GRIM-19 function in cancer development
Moreira, S., Correia, M., Soares, P., & Máximo, V. (2011) · Mitochondrion · doi:10.1016/j.mito.2011.05.011 · Cited by 33
STAT3 Serine 727 Phosphorylation: A Relevant Target to Radiosensitize Human Glioblastoma
Ouédraogo, Z. G., Müller‐Barthélémy, M., Kemeny, J., Dedieu, V., Biau, J., Khalil, T., Raoelfils, L. I., Granzotto, A., Pereira, B., Beaudoin, C., et al. (2016) · Brain Pathology · doi:10.1111/bpa.12254 · Cited by 33
Regulation of STAT pathways and IRF1 during human dendritic cell maturation by TNF-α and PGE2
Hu, Y., Park‐Min, K., Yarilina, A., & Ivashkiv, L. B. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0107040 · Cited by 32
Protein tyrosine phosphatase 1B expression contributes to the development of breast cancer
Liao, S., Li, J., Yu, L., & Sun, S. (2017) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1600184 · Cited by 31
Targeting STAT3 with Proteolysis Targeting Chimeras and Next-Generation Antisense Oligonucleotides
Shiah, J. V., Grandis, J. R., & Johnson, D. E. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0599 · Cited by 32
GRIM-19 opposes reprogramming of glioblastoma cell metabolism via HIF1α destabilization
Liu, Q., Wang, L., Wang, Z., Yang, Y., Tian, J., Liu, G., Guan, D., Cao, X., Zhang, Y., & Hao, A. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt125 · Cited by 32
Thaper, D., Vahid, S., Kaur, R., Kumar, S., Nouruzi, S., Bishop, J. L., Johansson, M., & Zoubeidi, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-35612-z · Cited by 34
Althagafy, H. S., El‐Aziz, M. K. A., Ibrahim, I. M., Abd‐alhameed, E. K., & Hassanein, E. H. M. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175776 · Cited by 35
Li, L., Sun, B., Gao, Y., Niu, H., Yuan, H., & Lou, H. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.02.026 · Cited by 32
STAT3 signaling in polycystic kidney disease
Weimbs, T., & Talbot, J. J. (2013) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2013.03.001 · Cited by 31
Intermolecular disulfide bond influences unphosphorylated STAT3 dimerization and function
Butturini, E., Gotte, G., Dell’Orco, D., Chiavegato, G., Marino, V., Canetti, D., Cozzolino, F., Monti, M., Pucci, P., & Mariotto, S. (2016) · Biochemical Journal · doi:10.1042/bcj20160294 · Cited by 31
Mukhopadhyay, S., Shah, M., Xu, F., Patel, K., Tuder, R. M., & Sehgal, P. B. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00377.2007 · Cited by 31
STAT nuclear translocation: potential for pharmacological intervention
Meyer, T., & Vinkemeier, U. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.10.1355 · Cited by 31
Exploring the IL-21–STAT3 Axis as Therapeutic Target for Sézary Syndrome
van der Fits, L., Out‐Luiting, J. J., Tensen, C. P., Zoutman, W. H., & Vermeer, M. H. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.199 · Cited by 30
Changing partners at the dance
Kallal, L. E., & Biron, C. A. (2013) · JAK-STAT · doi:10.4161/jkst.23504 · Cited by 30
Zhang, Z., Mao, H., Du, X., Zhu, J., Xu, Y., Wang, S., Xu, X., Ji, P., Yu, Y., Cao, B., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.6974 · Cited by 30
Kim, S. J., & Yoon, S. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.17 · Cited by 30
Arévalo, J., Campoy, I., Durán, M., Nemours, S., Areny‐Balagueró, A., Vall‐Palomar, M., Martínez, C., Cantero-Recasens, G., & Meseguer, A. (2023) · Scientific Reports · doi:10.1038/s41598-023-46628-5 · Cited by 29
Integration of HIV-1 caused STAT3-associated B cell lymphoma in an AIDS patient
Katano, H., Sato, Y., Hoshino, S., Tachikawa, N., Oka, S., Morishita, Y., Ishida, T., Watanabe, T., Rom, W. N., Mori, S., et al. (2007) · Microbes and Infection · doi:10.1016/j.micinf.2007.09.008 · Cited by 29
Nallar, S. C., Kalakonda, S., Lindner, D. J., Lorenz, R. R., Lamarre, E., Weihua, X., & Kalvakolanu, D. V. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.440610 · Cited by 29
Bernadó, P., Pérez, Y., Blobel, J., Fernández‐Recio, J., Svergun, D. I., & Pons, M. (2009) · Protein Science · doi:10.1002/pro.83 · Cited by 29
Transcription factor Stat5a/b as a therapeutic target protein for prostate cancer
Liao, Z., Lutz, J., & Nevalainen, M. T. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.11.001 · Cited by 29
O-GlcNAcylation mediates H2O2-induced apoptosis through regulation of STAT3 and FOXO1
Zhang, C.-C., Li, Y., Jiang, C., Le, Q., Liu, X., Ma, L., & Wang, F. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01218-z · Cited by 28
Du, Z., Fan, M., Kim, J.-G., Eckerle, D., Lothstein, L., Wei, L., & Pfeffer, L. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.028324 · Cited by 28
Oladipupo, F. O., Yu, C., Olumuyide, E., Jittaysothorn, Y., Choi, J. K., & Egwuagu, C. E. (2020) · Scientific Reports · doi:10.1038/s41598-020-73093-1 · Cited by 28
Kalakonda, S., Nallar, S. C., Gong, P., Lindner, D. J., Goldblum, S. E., Reddy, S. P., & Kalvakolanu, D. V. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070241 · Cited by 28
Serpin B3/B4, activated by STAT3, promote survival of squamous carcinoma cells
Ahmed, S. T., & Darnell, J. E., Jr. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.11.147 · Cited by 27
Uluer, E. T., Aydemir, I., İnan, S., Özbilgin, K., & Vatansever, S. (2011) · Acta Histochemica · doi:10.1016/j.acthis.2011.11.010 · Cited by 27
The role of interleukin-6 in gynaecological malignancies
Coward, J. I. G., & Kulbe, H. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.08.005 · Cited by 26
Venuto, S., Castellana, S., Monti, M., Appolloni, I., Fusilli, C., Fusco, C., Pucci, P., Malatesta, P., Mazza, T., Merla, G., et al. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2018.12.001 · Cited by 26
The pro- and anti-tumor roles of mesenchymal stem cells toward BRCA1-IRIS-overexpressing TNBC cells
Ryan, D., Paul, B. T., Koziol, J., & ElShamy, W. M. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1131-2 · Cited by 25
Interferon Independent Non-Canonical STAT Activation and Virus Induced Inflammation
Nan, Y., Wu, C., & Zhang, Y. (2018) · Viruses · doi:10.3390/v10040196 · Cited by 26
Expression and prognostic relevance of STAT3 and cyclin D1 in non-small cell lung cancer
Ai, T., Wang, Z., Zhang, M., Zhang, L., Wang, N., Li, W., & Song, L. (2012) · The International Journal of Biological Markers · doi:10.5301/jbm.2012.9146 · Cited by 25
Cytokine-induced tumor suppressors: A GRIM story
Kalvakolanu, D. V., Nallar, S. C., & Kalakonda, S. (2010) · Cytokine · doi:10.1016/j.cyto.2010.03.009 · Cited by 25
Chen, X., Jiang, Y., Li, Y., Zhang, H., Li, J., Chen, X., Zhao, Q., Zhao, J. H., Si, J., Lin, Z., et al. (2011) · Extremophiles · doi:10.1007/s00792-011-0380-5 · Cited by 25
Molecular Action of Polyphenols in Leukaemia and Their Therapeutic Potential
Alaswad, H. A., Mahbub, A. A., Maitre, C. L. L., & Jordan, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063085 · Cited by 26
Lou, C., Chen, Y., Zhang, J., Yang, B., & Zhao, H. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01071 · Cited by 24
RetractedSTAT3 Inhibitors in Cancer: A Comprehensive Update
Bharadwaj, U., Kasembeli, M. M., & Tweardy, D. J. (2016) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-42949-6_5 · Cited by 24
Fu, Z., Li, S., Liu, J., Zhang, C., Chen, J., Wang, L., Zhang, Y., & Chen, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.847906 · Cited by 25
Han, Z., Hong, Z., Gao, Q., Chen, C., Zhou, H., Ji, T., Hu, W., Yan, Y., Feng, J., Liao, S., et al. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.101 · Cited by 24
Impact of IFNα2b upon pSTAT3 and the MEK/ERK MAPK Pathway in Melanoma
Wang, W., Edington, H. D. J., Jukic, D. M., Rao, U. N. M., Land, S. R., & Kirkwood, J. M. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0466-9 · Cited by 22
Han, Z., Hong, Z., Chen, C., Gao, Q., Luo, D., Fang, Y., Cao, Y., Zhu, T., Jiang, X., Ma, Q., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp249 · Cited by 24
SHF Acts as a Novel Tumor Suppressor in Glioblastoma Multiforme by Disrupting STAT3 Dimerization
Wang, J., Huang, Z., Ji, L., Chen, C., Wan, Q., Xin, Y., Pu, Z., Li, K., Jiao, J., Yin, Y., et al. (2022) · Advanced Science · doi:10.1002/advs.202200169 · Cited by 22
The logic of communication: roles for mobile transcription factors in plants
Long, Y., Scheres, B., & Blilou, I. (2015) · Journal of Experimental Botany · doi:10.1093/jxb/eru548 · Cited by 25
Alternative ways of modulating JAK-STAT pathway
Timofeeva, O. A., & Tarasova, N. I. (2012) · JAK-STAT · doi:10.4161/jkst.22313 · Cited by 22
Pfeffer, S. R., Fan, M., Du, Z., Yang, C. H., & Pfeffer, L. M. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.06.111 · Cited by 21
BCL9/STAT3 regulation of transcriptional enhancer networks promote DCIS progression
Elsarraj, H. S., Hong, Y., Limback, D., Zhao, R., Berger, J., Bishop, S., Sabbagh, A., Oppenheimer, L., Harper, H., Tsimelzon, A. I., et al. (2020) · npj Breast Cancer · doi:10.1038/s41523-020-0157-z · Cited by 20
Chen, L., Zhang, Q., Chen, G., Qian, Y., Shi, B., & Dong, J. (2010) · Liver Transplantation · doi:10.1002/lt.21985 · Cited by 20
Lee, S. W., Ahn, Y. Y., Kim, Y. S., Kang, S. B., Nam, S. W., Lee, D. S., Jeong, H. Y., & Kim, J. (2012) · Gut and Liver · doi:10.5009/gnl.2012.6.1.45 · Cited by 19
Zhang, Y., Liao, S., FAN, W., Wei, W., Wang, C., & Sun, S. (2014) · Oncology Reports · doi:10.3892/or.2014.3479 · Cited by 20
Effects of STAT3 silencing on fate of chronic myelogenous leukemia K562 cells
Ma, L., Zhou, M., Shi-hong, W., Ni, C., Jiang, L., Fan, J., & Xia, L. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2010.483748 · Cited by 19
Structural determinants of mitochondrial STAT3 targeting and function
Marié, I. J., Lahiri, T., Önder, Ö., Elenitoba‐Johnson, K. S. J., & Levy, D. E. (2024) · Mitochondrial Communications · doi:10.1016/j.mitoco.2024.01.001 · Cited by 20
Self-citationSmad7 Sustains Stat3 Expression and Signaling in Colon Cancer Cells
Maresca, C., Maggio, G. D., Stolfi, C., Laudisi, F., Colella, M., Pacifico, T., Grazia, A. D., Fusco, D. D., Congiu, D., Guida, A. M., et al. (2022) · Cancers · doi:10.3390/cancers14204993 · Cited by 18
STAT3: An Anti-Invasive Factor in Colorectal Cancer?
de Jong, P. R., Mo, J., Harris, A., Lee, J., & Raz, E. (2014) · Cancers · doi:10.3390/cancers6031394 · Cited by 18
Ablation of STAT3 in the B Cell Compartment Restricts Gammaherpesvirus Latency In Vivo
Reddy, S., Foreman, H., Sioux, T. O., Park, G. H., Poli, V., Reich, N., & Krug, L. (2016) · mBio · doi:10.1128/mbio.00723-16 · Cited by 17
Ray, S., Coulter, D. W., Gray, S. D., Sughroue, J. A., Roychoudhury, S., McIntyre, E. M., Chaturvedi, N. K., Bhakat, K. K., Joshi, S. S., McGuire, T. R., et al. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22778 · Cited by 18
Adach, A., Swiatek-Machado, K., Kaminska, B., & Dąbrowski, M. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23305 · Cited by 18
Nuclear unphosphorylated STAT3 correlates with a worse prognosis in human glioblastoma
Rodrigues, B. R., Queiroz‐Hazarbassanov, N., Lopes, M. H., Bleggi-Torres, L. F., Suzuki, S. H., da Cunha, I. W., Sanematsu, P., & Martins, V. R. (2016) · Pathology - Research and Practice · doi:10.1016/j.prp.2016.03.001 · Cited by 17
Reduced STAT3 activity in mice mimics clinical disease syndromes
Shen, Y., Perle, K. M. D. L., Levy, D. E., & Darnell, J. E., Jr. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.154 · Cited by 17
Self-citationSystemic evaluation of total Stat3 and Stat3 tyrosine phosphorylation in normal human tissues
Chen, C., Hsieh, F.-C., & Lin, J. (2006) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2005.11.003 · Cited by 17
Functional antibody delivery: Advances in cellular manipulation
Koch, K. C., & Tew, G. N. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114586 · Cited by 16
Natural STAT3 Inhibitors for Cancer Treatment: A Comprehensive Literature Review
Zarezadeh, S. M., Sharafi, A. M., Erabi, G., Tabashiri, A., Teymouri, N., Mehrabi, H., Golzan, S. A., Faridzadeh, A., Abdollahifar, Z., Sami, N., et al. (2023) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892818666230803100554 · Cited by 18
Chen, J., Ren, J., Zhang, W., & Li, J. (2011) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e3182325e02 · Cited by 15
The Jak-STAT Signal Transduction Pathway in Melanoma
Nicholas, C., & Gregory, B. (2011) · InTech eBooks · doi:10.5772/18876 · Cited by 19
Thymidine phosphorylase inhibits vascular smooth muscle cell proliferation via upregulation of STAT3
Yue, H., Tanaka, K., Furukawa, T., Karnik, S. S., & Li, W. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.05.025 · Cited by 13
Identification of Lead Compounds as Inhibitors of STAT3: Design, Synthesis and Bioactivity
Botta, A., Sirignano, E., Popolo, A., Saturnino, C., Terracciano, S., Foglia, A., Sinicropi, M. S., Longo, P., & Micco, S. D. (2015) · Molecular Informatics · doi:10.1002/minf.201500043 · Cited by 16
McLaren, J. E., Rowe, M., & Brennan, P. (2007) · Journal of General Virology · doi:10.1099/vir.0.82741-0 · Cited by 16
Interferon Research: Impact on Understanding Transcriptional Control
Darnell, J. E., Jr. (2007) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-71329-6_8 · Cited by 16
Sun, Z., Sun, X., Qin, G., Li, Y., Zhou, G., & Jiang, X. (2023) · Epigenetics · doi:10.1080/15592294.2023.2242688 · Cited by 15
Ji, W., Chuang, Y., Chen, H.-P., Lee, C., Chen, J. Y., Yang, S., Chen, J.-H., Wang, C.-J., & Chen, H. (2014) · Toxicology Reports · doi:10.1016/j.toxrep.2014.10.018 · Cited by 15
Serine phosphorylation of the Stat5a C-terminus is a driving force for transformation
Friedbichler, K. (2011) · Frontiers in bioscience · doi:10.2741/3897 · Cited by 15
Guo, X., Stratton, L., & Schrader, J. W. (2006) · Oncogene · doi:10.1038/sj.onc.1209452 · Cited by 15
Activation of Interleukin-6/STAT3 in Rat Cholangiocyte Proliferation Induced by Lipopolysaccharide
Chen, L., Cai, M., Zhang, Q., Li, Z., Qian, Y., Bai, H., Wei, X., Shi, B., & Dong, J. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0401-0 · Cited by 15
Pharmacological targeting of the JAK–STAT pathway: new concepts and emerging indications
Haikarainen, T., Virtanen, A. T., Cravatt, B. F., & Silvennoinen, O. (2026) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01336-9 · Cited by 17
M-Ras is Muscle-Ras, Moderate-Ras, Mineral-Ras, Migration-Ras, and Many More-Ras
Endo, T. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112342 · Cited by 14
Metadata
- Authors
- Yang, J., Chatterjee-Kishore, M., Staugaitis, S. M., Nguyen, H., Schlessinger, K., Levy, D. E., & Stark, G. R.
- Affiliations
- 1Molecular Biology and Departments of
- Cleveland Clinic (US)
- New York University (US)
- Venue
- Cancer Research
- Published
- 2005-02-01
- Volume
- 65
- Issue
- 3
- Pages
- 939-947
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2147314043
- Cited by
- 405
- References
- 38
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 11 · 2023: 15 · 2022: 14 · 2021: 14 · 2020: 16 · 2019: 13 · 2018: 20 · 2017: 18 · 2016: 20 · 2015: 19 · 2014: 22 · 2013: 29 · 2012: 24
- FWCI
- 12.95
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cleveland Clinic
- Johns Hopkins University
- National Institutes of Health
- School of Medicine, Indiana University
- National Cancer Institute (P01CA062220)
- National Institute of Allergy and Infectious Diseases (R01AI028900)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- STAT3, tyrosine 705 phosphorylation, carcinogenesis, transcriptional regulation, interleukin-6, cytokine response, oncoprotein, mineralocorticoid receptor antagonists, MET, constitutive STAT3 activation, gene expression, mammary epithelial cells
- MeSH terms
- Animals, DNA-Binding Proteins, Female, Gene Expression Regulation, Humans, Neoplasms, Oncogenes, Phosphorylation, Proto-Oncogene Proteins, RNA, Messenger, Trans-Activators, Interleukin-6, Gene Expression Regulation, Neoplastic, Receptors, Growth Factor, ras Proteins, Proto-Oncogene Proteins c-met, Monomeric GTP-Binding Proteins, Mammary Glands, Human, STAT3 Transcription Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review